lapatinib has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Khatib, AS; F Mohamed, A; Khattab, MM; Mansour, HM | 1 |
1 other study(ies) available for lapatinib and Parkinson Disease
| Article | Year |
|---|---|
Lapatinib ditosylate rescues motor deficits in rotenone-intoxicated rats: Potential repurposing of anti-cancer drug as a disease-modifying agent in Parkinson's disease.
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Dopaminergic Neurons; Drug Repositioning; Lapatinib; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Rats; Rotenone | 2023 |